Special clinical interests in pancreatic cancer, biliary cancer, liver cancer, neuroendocrine tumours and melanoma.
Dr Corrie qualified in medicine at Oxford University, having already undertaken a PhD in anti-cancer drug development. She undertook specialist training in Medical Oncology in Birmingham before being appointed as Consultant at Cambridge University Hospitals NHS Foundation Trust (Addenbrooke’s Hospital) in 1996 and subsequently Associate Lecturer at the University of Cambridge. She has been closely involved in developing modern therapeutics for melanoma and pancreaticobiliary cancers.
Dr Corrie holds national roles in the National Institute of Health Research and National Cancer Research Institute. She is the chief investigator of multiple academic and industry-sponsored national and international clinical trials. She has published widely in high impact journals.
- Targeted therapy
NHS Hospital / current post(s)
- Consultant and Associate Lecturer in Medical Oncology, Addenbrooke’s Hospital Cambridge, and the University of Cambridge
- Melanoma evolution and treatment
- Pancreaticobiliary cáncer systemic therapies
- Experimental therapeutics
- Immunotherapy biomarkers of response and toxicity
- Fellow of the Royal College of Physicians (FRCP)
- Member of the British Association for Cancer Research
- Member of the American Society of Clinical Oncology
- Member of the European Organisation for Research and Treatment of Cancer – Melanoma and Gastro-intestinal Cancer Groups
- Member of the Medical Defence Union
- Chair, National Cancer Research Institute Pancreatic Workstream
- Melanoma Focus Charity Trustee